HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

SCT Logistics has announced the acquisition of Tasmanian business CRE Solutions Logistics to improve its market presence in Australia’s island state. CRE was established in 2007 and offers daily Trans ...

Not peer-reviewed: This work has not been scrutinised by independent experts, or the story does not contain research data to review (for example an opinion piece). If you are reporting on research ...

The Australian Nuclear Science and Technology Organisation (ANSTO) is home to Australian’s nuclear science and technical expertise. ANSTO, an Australian Government funded organisation, operates ...

Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial.

Plus Therapeutics (PSTV) announces that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Rhenium Obisbemeda for the treatment of leptomeningeal metastases in patients ...

The Australian Nuclear Science & Technology Organisation (ANSTO) has launched a key decommissioning project marking the end of an era for Australia’s first nuclear research reactor at Lucas Heights, ...

School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology Key Laboratory of Material Chemistry for Energy Conversion and Storage (Huazhong University of Science and ...

MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, China The Marine Biomedical Research Institute of Guangdong Zhanjiang, School ...